miRNA-29b-RTKN 对人乳腺癌细胞凋亡的影响及机制研究
摘要
方法 构建 RTKN 过表达、miRNA-29b 过表达细胞,将细胞分组为 1)NC/ 空载体组、2)RTKN 过表达组、3)miRNA-
29b 过表达组、4)miRNA-29b&RTKN 均过表达组、5)miRNA-29b 过表达 +NF-κB 抑制剂组、6)NF-κB 抑制剂组,
采用流式细胞法对各组细胞进行凋亡率及细胞周期分布情况的测定,同时利用 Western blot 法分析细胞周期相关因子(包
括 cyclinD1、c-myc、CDK1、CDK2、MCM6)和细胞抗凋亡相关因子(如 c-IAP2、BCL-xL)的表达情况。结果 与 NC/
空载体组相比,RTKN 过表达组细胞周期相关蛋白及细胞抗凋亡相关因子的表达显著提高(p<0.05),肿瘤细胞凋亡率明
显下降(p<0.01),而 miRNA-29b 过表达细胞实验结果则恰好相反(p<0.05)。与 NC 组相比,miRNA-29b 过表达组
及 NF-κB 抑制剂组的肿瘤细胞周期相关蛋白及细胞抗凋亡相关因子的表达显著减少(p<0.05),细胞 G0/G1 期显著延长
(p<0.05),肿瘤细胞的凋亡率也明显提高(p<0.01);与 miRNA-29b 过表达组及 NF-κB 抑制剂组相较,miRNA-29b
过表达 +NF-κB 抑制剂组的肿瘤细胞周期相关蛋白及细胞抗凋亡相关因子的表达显著减少(p<0.05),细胞 G0/G1 期显
著延长(p<0.05),肿瘤细胞的凋亡率也较之明显提高(p<0.01)。结论 miRNA-29b-RTKN 对乳腺癌细胞的凋亡的调控
是通过 NF-κB 信号通路实现的,可以为乳腺癌药物的研发及治疗提供新的方向。
关键词
全文:
PDF参考
[1]KWON J J, FACTORA T D, DEY S, et al. A Systematic
Review of miR-29 in Cancer [J]. Mol Ther Oncolytics, 2019, 12:
173-94.
[2]AMIRIAN M, JAFARI-NOZAD A M, DARROUDI M, et
al. Overview of the miR-29 family members’ function in breast
cancer [J]. Int J Biol Macromol, 2023, 230: 123280.
[3]BOTTA C, CUCE M, PITARI M R, et al. MiR-29b
antagonizes the pro-inflammatory tumor-promoting activity of
multiple myeloma-educated dendritic cells [J]. Leukemia, 2018,
32(4): 1003-15.
[4]DEMIR CETINKAYA B, BIRAY AVCI C. Molecular
perspective on targeted therapy in breast cancer: a review of
current status [J]. Med Oncol, 2022, 39(10): 149.
[5]LI B, CHEN P, CHANG Y, et al. Let-7a inhibits tumor
cell growth and metastasis by directly targeting RTKN in human
colon cancer [J]. Biochem Biophys Res Commun, 2016, 478(2):
739-45.
[6]ITO H, MORISHITA R, NAGATA K I. Functions of
Rhotekin, an Effector of Rho GTPase, and Its Binding Partners in
Mammals [J]. Int J Mol Sci, 2018, 19(7).
[7] 姜贻乾 , 郭庆敏 , 谷建钟 , 等 . 微小 RNA-29b 对乳腺
癌细胞增殖和迁移的影响及其分子生物学机制 [J]. 浙江大学
学报 ( 医学版 ), 2017, (04): 349-56.
[8]LALLE G, TWARDOWSKI J, GRINBERG-BLEYER Y.
NF-kappaB in Cancer Immunity: Friend or Foe? [J]. Cells, 2021,
10(2).
[9]QUINN J A, BENNETT L, PATEL M, et al. The
relationship between members of the canonical NF-kB pathway,
tumour microenvironment and cancer specific survival in
colorectal cancer patients [J]. Histol Histopathol, 2020, 35(6):
569-78.
[10]RAMADASS V, VAIYAPURI T, TERGAONKAR V.
Small Molecule NF-kappaB Pathway Inhibitors in Clinic [J]. Int J
Mol Sci, 2020, 21(14).
[11]ZHANG M, LIU Z Z, AOSHIMA K, et al. CECR2 drives
breast cancer metastasis by promoting NF-kappaB signaling and
macrophage-mediated immune suppression [J]. Sci Transl Med,
2022, 14(630): eabf5473.
[12]PAVITRA E, KANCHARLA J, GUPTA V K, et al. The
role of NF-kappaB in breast cancer initiation, growth, metastasis,
and resistance to chemotherapy [J]. Biomed Pharmacother, 2023,
163: 114822.
[13]ZHOU J, ZHANG Y, QI Y, et al. MicroRNA-152 inhibits
tumor cell growth by directly targeting RTKN in hepatocellular
carcinoma [J]. Oncol Rep, 2017, 37(2): 1227-34.
[14]QU G Q, LU Y M, LIU Y F, et al. Effect of RTKN on
progression and metastasis of colon cancer in vitro [J]. Biomed
Pharmacother, 2015, 74: 117-23.
[15]LIU C A, WANG M J, CHI C W, et al. Rho/Rhotekinmediated NF-kappaB activation confers resistance to apoptosis [J].
Oncogene, 2004, 23(54): 8731-42.
[16]WU J, DING J, YANG J, et al. MicroRNA Roles in the
Nuclear Factor Kappa B Signaling Pathway in Cancer [J]. Front
Immunol, 2018, 9: 546.
[17]DRAGO-FERRANTE R, PENTIMALLI F, CARLISI D,
et al. Suppressive role exerted by microRNA-29b-1-5p in triple
negative breast cancer through SPIN1 regulation [J]. Oncotarget,
2017, 8(17): 28939-58.
(7 摘要 Views, 8 PDF Downloads)
Refbacks
- 当前没有refback。